Cross-Species Organ Transplantation Market Emerging Trends and Growth Drivers Through 2029 | Reach USD $20.94 Billion
Uncover key drivers, emerging technologies, and competitive movements shaping the cross-species organ transplantation market from 2025–2034 with trusted insights from The Business Research Company
How Big Is The Cross-Species Organ Transplantation Market Today And What Is Its Future Size?
The cross-species organ transplantation market has experienced substantial growth in recent years. Its valuation is anticipated to climb from $13.98 billion in 2024 to $15.20 billion in 2025, reflecting a compound annual growth rate (CAGR) of 8.7%. Historically, this market expansion can be linked to animal model experimentation, the development of bioethics discussions, the increasing prevalence of chronic diseases, experimental pig-to-primate transplants, and the high mortality associated with end-stage organ failure.
The cross-species organ transplantation market size is anticipated to undergo significant expansion over the next few years. It is forecast to achieve a value of $20.95 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 8.3%. This expansion during the forecast period can be primarily attributed to a growing need for transplantable organs, increasing investments directed towards regenerative medicine, the worldwide prevalence of chronic kidney and liver diseases, advocacy from patients seeking greater access to transplants, and the diminishing availability of human donors. Significant trends identified for this period include the production of gene-edited pig organs, human-compatible genome engineering, the application of artificial intelligence in organ matching, the 3D bioprinting of vascular structures, advancements in machine perfusion and preservation technology, and nanoscale drug delivery systems for immunosuppression.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27267&type=smp
What External And Internal Drivers Are Influencing The Cross-Species Organ Transplantation Market?
The increasing adoption of genetic engineering is anticipated to drive the expansion of the cross-species organ transplantation market. Genetic engineering involves the intentional alteration of an organism’s DNA via biotechnology methods to insert, remove, or change particular genes. This rise in genetic engineering stems from the critical demand to resolve organ scarcity by developing animal organs more compatible for human transplants. It facilitates the growth of cross-species organ transplantation by allowing the modification of animal organs to decrease immune rejection, thus making them suitable for human implantation. For example, in July 2023, as reported by the American Society of Gene & Cell Therapy (ASGCT), a US-based non-profit medical and scientific organization, there were 247 gene therapies in Phase II by the end of first quarter of 2023, which grew by 5% to reach 260 by the end of the second quarter. Consequently, the increasing trend towards genetic engineering is fueling the growth of the cross-species organ transplantation market.
How Is The Cross-Species Organ Transplantation Market Categorized Across Applications And Types?
The cross-species organ transplantation market covered in this report is segmented
1) By Product Type: Organ Preservation Solution, Transplant Diagnostics, Xeno Products, Other Product Types
2) By Application: Kidney, Heart, Liver, Lung, Other Applications
3) By End-User: Transplant Centers, Hospitals, Other End-Users
Subsegments:
1) By Organ Preservation Solution: Hypothermic Machine Perfusion (HMP) Solutions, Normothermic Machine Perfusion (NMP) Solutions, Static Cold Storage (SCS) Solutions, Oxygenated Perfusion Solutions
2) By Transplant Diagnostics: Histocompatibility Testing, Crossmatching Tests, Molecular Typing (DNA-based Testing), Immunological Monitoring Assays
3) By Xeno Products: Genetically Engineered Donor Organs, Decellularized Organ Scaffolds, Xenogeneic Cellular Therapies, Immunosuppressive Regimens For Xenotransplants
4) By Other Product Types: Organ Transport Devices, Organ Recovery and Preservation Equipment, Surgical Instruments For Transplantation, Post-Transplant Monitoring Devices
How Are Market Trends Influencing Competition In The Cross-Species Organ Transplantation Market?
Leading firms within the cross-species organ transplantation market are prioritizing the formation of strategic alliances to expedite the regulatory clearance pathway for xenotransplantation products. Such a partnership involves companies collaborating to reach shared objectives by leveraging their respective capabilities and assets, intending to foster expansion, creativity, and market advantage without consolidation. An example of this is the collaboration set for February 2025, where United Therapeutics, a US-based biotechnology firm, and eGenesis, a US-based pharmaceutical enterprise, will commence clinical trials involving pig kidney (xenotransplant) transplants into human subjects. The U.S. Food and Drug Administration (FDA) granted permission for these trials, allowing the transplantation of genetically altered pig kidneys into individuals suffering from kidney failure. The purpose of these trials is to alleviate the severe scarcity of donor kidneys by offering a potentially novel and enduring organ supply for patients requiring them.
Who Are The Global Leaders Steering The Cross-Species Organ Transplantation Market Forward?
Major companies operating in the cross-species organ transplantation market are Pfizer Inc, F. Hoffmann-la Roche Ltd, Sanofi SA, Novartis AG, Optipharm Co Ltd, Astellas Pharma Inc., United Therapeutics Corporation, TransMedics Group Inc., Artivion Inc., eGenesis Inc., Organ Recovery Systems Inc., OrganOX Ltd, Paragonix Technologies Inc., Qihan Biotech, PorMedTec Co., XenoTheraputics Inc., Makana Therapeutics Inc., Preservation Solutions Inc., Nzeno Ltd, Infigen Inc.
Access The Complete Report Here:
What Are The Emerging Regional Trends Driving The Cross-Species Organ Transplantation Market?
North America was the largest region in the cross-species organ transplantation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cross-species organ transplantation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=27267&type=smp
Browse Through More Reports Similar to the Global Cross-Species Organ Transplantation Market 2025, By The Business Research Company
Landscaping Services Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/landscaping-services-global-market-report
Crop Production Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/crop-production-global-market-report
Agriculture And Forestry Services Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
